Brief: Sedana Medical's U.S. Trial InspIre-ICU 1 Meets Primary Endpoint

Sedana Medical AB (publ)

20/12/2024 07:08

Dec 20 (Reuters) - Sedana Medical AB  SEDANA.ST :
    * SAID ON THURSDAY FIRST PIVOTAL US TRIAL INSPIRE-ICU 1 HAS
MET
ITS PRIMARY ENDPOINT
    * SAFETY RESULTS WERE IN LINE WITH EXPECTATIONS
    * HIGH-LEVEL RESULTS FOR INSPIRE-ICU 2 ARE EXPECTED IN EARLY
2025

        
 Source text for Workspace:  urn:newsml:reuters.com:*:nMFN1z6fXr
 Further company coverage:  SEDANA.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))